Real-world clinical evidence on rivaroxaban, dabigatran, and apixaban compared with vitamin K antagonists in patients with nonvalvular atrial fibrillation: a systematic …

JB Briere, K Bowrin, C Coleman… - Expert Review of …, 2019 - Taylor & Francis
Introduction: Several comparative real-world effectiveness studies on direct oral
anticoagulants (DOACs) have been conducted, but an overview of the available evidence …

[引用][C] Real-world clinical evidence on rivaroxaban, dabigatran, and apixaban compared with vitamin K antagonists in patients with nonvalvular atrial fibrillation: a …

JB Briere, K Bowrin, C Coleman, L Fauchier… - Expert Review of …, 2019 - hal.science
Real-world clinical evidence on rivaroxaban, dabigatran, and apixaban compared with vitamin
K antagonists in patients with nonvalvular atrial fibrillation: a systematic literature review …

Real-world clinical evidence on rivaroxaban, dabigatran, and apixaban compared with vitamin K antagonists in patients with nonvalvular atrial fibrillation: a systematic …

JB Briere, K Bowrin, C Coleman… - Expert review of …, 2019 - pubmed.ncbi.nlm.nih.gov
Introduction Several comparative real-world effectiveness studies on direct oral
anticoagulants (DOACs) have been conducted, but an overview of the available evidence …

Real-world clinical evidence on rivaroxaban, dabigatran, and apixaban compared with vitamin K antagonists in patients with nonvalvular atrial fibrillation: a systematic …

JB Briere, K Bowrin, C Coleman, L Fauchier… - Expert Review of …, 2018 - europepmc.org
This article has been corrected. See Expert Rev Pharmacoecon Outcomes Res. 2019 Jun
20;: 1. A comment on this article appears in" Real-world clinical evidence on rivaroxaban …

Real-world clinical evidence on rivaroxaban, dabigatran, and apixaban compared with vitamin K antagonists in patients with non-valvular atrial fibrillation: a …

JB Briere, K Bowrin, C Coleman… - Expert Review of …, 2019 - eprints.gla.ac.uk
Introduction Several comparative real-world effectiveness studies on direct oral
anticoagulants (DOACs) have been conducted, but an overview of the available evidence …

Real-world clinical evidence on rivaroxaban, dabigatran, and apixaban compared with vitamin K antagonists in patients with nonvalvular atrial fibrillation: a systematic …

JB Briere, K Bowrin, C Coleman, L Fauchier… - Expert Review of …, 2018 - europepmc.org
This article has been corrected. See Expert Rev Pharmacoecon Outcomes Res. 2019 Jun
20;: 1. A comment on this article appears in" Real-world clinical evidence on rivaroxaban …